Evidence map›Paper›PMID 11226276›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

Interaction of a transcriptional repressor with the RNA polymerase II holoenzyme plays a crucial role in repression.

Z Zaman, A Z Ansari, S S Koh, R Young, M Ptashne

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. TheG3 (Bethesda, Md.) · 2017
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Transcriptional activating regions target attached substrates to a cyclin-dependent kinase.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Z ZamanMolecular Biology Program, Sloan Kettering Institute, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.
A Z Ansari
S S Koh
R Young
M Ptashne
Massachusetts Institute of Technology · USMemorial Sloan Kettering Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The yeast transcriptional repressor Tup1, tethered to DNA, represses to strikingly different degrees transcription elicited by members of two classes of activators. Repression in both cases is virtually eliminated by mutation of either member of the cyclin-kinase pair Srb10/11. In contrast, telomeric chromatin affects both classes of activators equally, and in neither case is that repression affected by mutation of Srb10/11. In vitro, Tup1 interacts with RNA polymerase II holoenzyme bearing Srb10 as well as with the separated Srb10. These and other findings indicate that at least one aspect of Tup1's action involves interaction with the RNA polymerase II holoenzyme.

Indexed as

Nuclear ProteinsSaccharomyces cerevisiae ProteinsCyclin-Dependent Kinase 8Cyclin-Dependent KinasesFungal ProteinsPromoter Regions, GeneticProtein BindingRepressor ProteinsRNA Polymerase IICyclin-Dependent Kinase 8Cyclin-Dependent KinasesFungal ProteinsNuclear ProteinsRepressor ProteinsRNA Polymerase IISaccharomyces cerevisiae ProteinsSSN3 protein, S cerevisiaeTUP1 protein, S cerevisiae

Identifiers

PMID11226276
PMCPMC30175
OpenAlexW2097843023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.